Vapotherm logo
Vapotherm VAPO

Quarterly report 2024-Q2
added 08-12-2024

report update icon

Vapotherm Balance Sheet 2011-2026 | VAPO

Annual Balance Sheet Vapotherm

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-4.39 M -7.54 M -50 M -114 M -26.4 M -23.7 M -4.56 M 6.11 M - - - - -

Long Term Debt

2.92 M 5.88 M 5.36 M - 41.8 M 31.3 M 18.9 M 9.46 M - - - - -

Long Term Debt Current

2.41 M 2.31 M 1.75 M 1.57 M - - - - - - - - -

Total Non Current Liabilities

- - - 15.2 M 42 M 31.6 M 172 M 118 M - - - - -

Total Current Liabilities

19.1 M 19.6 M 43.2 M 42 M 16.2 M - - - - - - - -

Total Liabilities

133 M 124 M 93.4 M 102 M 58.2 M 45.7 M 187 M 127 M - - - - -

Deferred Revenue

1.04 M 1.02 M 1.71 M 6 K 481 K 79 K 64 K 63 K - - - - -

Retained Earnings

-548 M -490 M -377 M - -265 M -214 M -172 M -141 M - - - - -

Total Assets

77.6 M 96.2 M 160 M 216 M 112 M 97.2 M 60.2 M 30.9 M - - - - -

Cash and Cash Equivalents

9.72 M 15.7 M 57.1 M 114 M 71.7 M 60 M - - - - - - -

Book Value

-55.3 M -28.2 M 66.7 M 114 M 53.7 M 51.6 M -127 M -96.3 M - - - - -

Total Shareholders Equity

-55.3 M -28.2 M 66.7 M 114 M 53.7 M 51.6 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Vapotherm

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

2.28 M 114 M 2.92 M - - - - 6.02 M - - 5.36 M - - - 6.78 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

149 M 140 M 133 M 128 M 125 M 123 M 124 M 124 M - 127 M 93.4 M 88.6 M 80.7 M 84 M 102 M 102 M 102 M 102 M 58.2 M 58.2 M 58.2 M 58.2 M 45.7 M 45.7 M 45.7 M 45.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

1.08 M 1.15 M 1.04 M 1.12 M 1.18 M 1.06 M 1.02 M 1.1 M - 1.27 M 1.71 M 1.79 M 1.24 M 959 K 2.52 M 2.52 M 2.52 M 2.52 M 344 K 344 K 344 K 344 K 251 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-577 M -563 M -548 M -538 M -523 M -508 M -490 M -469 M - -400 M -377 M -358 M -345 M -327 M -317 M -317 M -317 M -317 M -265 M -265 M -265 M -265 M -214 M -214 M -214 M -214 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

67.9 M 71.9 M 77.6 M 80.6 M 90.1 M 101 M 96.2 M 113 M - 181 M 160 M 171 M 174 M 191 M 216 M 216 M 216 M 216 M 112 M 112 M 112 M 112 M 97.2 M 97.2 M 97.2 M 97.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

2.9 M 3.3 M 9.72 M 14.4 M 18 M 25.7 M 15.7 M 28.7 M - 72.9 M 57.1 M 70.3 M 81.5 M 93.8 M 114 M 114 M 114 M 114 M 71.7 M 71.7 M 71.7 M 71.7 M 58.2 M 58.2 M 58.2 M 58.2 M 26.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

-81.3 M -68.5 M -55.3 M -47.5 M -34.5 M -22.4 M -28.2 M -10.9 M - 53.9 M 66.7 M 82.2 M 93.2 M 107 M 114 M 114 M 114 M 114 M 53.7 M 53.7 M 53.7 M 53.7 M 51.6 M 51.6 M 51.6 M 51.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

-81.3 M -68.5 M -55.3 M -47.5 M -34.5 M -22.4 M -28.2 M -10.9 M 13.7 M 53.9 M 66.7 M 82.2 M 93.2 M 107 M 114 M 114 M 114 M 114 M 53.7 M 53.7 M 53.7 M 53.7 M 51.6 M 51.6 M 51.6 M 51.6 M -127 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Vapotherm, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Electromed Electromed
ELMD
$ 25.1 - $ 212 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.98 - $ 1.2 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 13.08 - $ 1.77 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.03 - $ 17.4 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 14.64 - $ 343 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 58.92 - $ 3.21 B britainBritain
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.31 - $ 124 M franceFrance
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 160.02 - $ 11.3 B usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 1.99 - $ 5.52 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 10.34 - $ 293 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 315.13 - $ 120 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 22.5 - $ 515 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.86 - $ 40.4 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.64 - $ 39.8 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
TransMedics Group TransMedics Group
TMDX
$ 98.57 - $ 3.35 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 18.16 - $ 1.24 B usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 11.03 - $ 457 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Vivos Therapeutics Vivos Therapeutics
VVOS
$ 0.78 - $ 8.01 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.92 - $ 1.04 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Globus Medical Globus Medical
GMED
$ 87.79 - $ 11.9 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 10.21 - $ 366 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 35.96 - $ 1.12 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 53.41 - $ 1.57 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 83.67 - $ 2.91 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 81.22 - $ 47.5 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA